Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wofsy

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The Journal of Rheumatology|February 24, 2001
Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosusJ C Davis, M C Totoritis, J Rosenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathwaysD I Daikh, B K Finck, P S Linsley, et al.
Clinical Immunology and Immunopathology|May 12, 1998
Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr miceM S Chesnutt, B K Finck, N Killeen, et al.
The Journal of Experimental Medicine|November 1, 1981
Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr geneD Wofsy, E D Murphy, J B Roths, et al.
Lupus|November 29, 2007
Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS)A Sinclair, G Appel, M A Dooley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985
Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cellsJ A Ledbetter, P J Martin, C E Spooner, et al.
Immunology|December 3, 1999
The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin GP Jeddi, J Keusch, P M Lydyard, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The Journal of Rheumatology|February 24, 2001
Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosusJ C Davis, M C Totoritis, J Rosenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathwaysD I Daikh, B K Finck, P S Linsley, et al.
Clinical Immunology and Immunopathology|May 12, 1998
Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr miceM S Chesnutt, B K Finck, N Killeen, et al.
The Journal of Experimental Medicine|November 1, 1981
Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr geneD Wofsy, E D Murphy, J B Roths, et al.
Lupus|November 29, 2007
Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS)A Sinclair, G Appel, M A Dooley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985
Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cellsJ A Ledbetter, P J Martin, C E Spooner, et al.
Immunology|December 3, 1999
The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin GP Jeddi, J Keusch, P M Lydyard, et al.
Pageof 6